Effect of Dengue Fever on Liver Enzymes

Authors

  • Taha Sahar, Alishba Abid, Rehmat Ullah, Alia Bibi Author

DOI:

https://doi.org/10.71395/ijhp.1.2.2024.52-56

Abstract

Background and Objectives: Dengue fever is a disease that is commonly found in endemic areas and is caused by the dengue virus which is spread by mosquitoes, specifically the Aedes aegypti mosquito. To determine the platelet count in dengue fever patients on the 5th day of diagnosis. To determine the correlation of dengue fever with liver enzyme.
METHODOLOGY: A retrospective study was conducted in the Bahria Hospital in Lahore, Pakistan. The study was conducted during the 3 months from May to July, 2023. The study included a total of 140 individuals with confirmed dengue fever, comprising 58 women and 82 men with ages ranging from 1 to 90. The study was conducted to determine the platelet count on the 5th day of diagnosis and to find out the correlation of dengue fever with liver enzymes. Patients were dived into 3 groups according to the age range 5-30, 31-60, and 61-90 years. Hematology results of these patients indicated low platelet count (<130×109/L). The instrument or machines we used for platelet count and liver enzyme measurement were Cell-DYN Ruby and Alinity ci-series respectively. A self-designed Performa was used to collect the patient data. Data were entered and analyzed by using excel and displayed by using Tables and Bar Charts.
RESULTS: According to the study, adults between the ages of 31 and 60 were most frequently affected by low platelet counts. Aspartate transaminase (AST), alanine transaminase (ALT), and alkaline phosphatase (ALP) levels were also found to be increased in individuals between the ages of 5 and 30 in 26%, 27%, and 8.5% of instances, respectively. The majority of patients with higher AST, ALT, and ALP values were between the ages of 31 and 60, with 53.5%, 52%, and 15.7% of patients displaying increased levels, respectively. In 14%, 14%, and 3.7% of patients between 61 and 90 years old, respectively, increased levels of AST, ALT, and ALP were found.
CONCLUSION: In conclusion, patients between the ages of 31 and 60 were found to have the highest prevalence of increased aminotransferases among all age categories, with AST and ALT levels being twice as high as ALP levels.

Author Biography

  • Taha Sahar, Alishba Abid, Rehmat Ullah, Alia Bibi

    Department of Pathology, The University of Faisalabad

References

Kabir A, Abdullah A, Sadeka M, Ahmed H, Kahhar M. The impact of dengue on liver function as evaluated by aminotransferase levels. J Med.

;9(2):66-8.

Roy SK, Bhattacharjee S. Dengue virus: epidemiology, biology, and disease aetiology. Canadian journal of microbiology. 2021;67(10):687-702.

Idrees S, Ashfaq UA. A brief review on dengue molecular virology, diagnosis, treatment and prevalence in Pakistan. Genetic vaccines and therapy. 2012;10:1-10.

Darwish NT, Alias YB, Khor SM. An introduction to dengue-disease diagnostics. TrAC Trends in Analytical Chemistry. 2015;67:45-55.

Pliego EP, Velázquez-Castro J, Collar AF. Seasonality on the life cycle of Aedes aegypti mosquito and its statistical relation with dengue outbreaks. Applied Mathematical Modelling. 2017;50:484-96.

Samanta J, Sharma V. Dengue and its effects on liver. World Journal of Clinical Cases: WJCC. 2015;3(2):125-128.

Harrison P. Platelet function analysis. Blood reviews. 2005;19(2):111-23.

Quirino-Teixeira AC, Andrade FB, Pinheiro MBM, Rozini SV, Hottz ED. Platelets in dengue infection: more than a numbers game. Platelets.

;33(2):176-83.

Lewis J, Mitra A, Chang M. Acute liver failure in a patient with dengue shock syndrome. ACG Case Reports Journal. 2020;7(4):37-39.

Mitra V, Metcalf J. Metabolic functions of the liver. Anaesthesia & Intensive Care Medicine. 2012;13(2):54-5.

Kalra A, Yetiskul E, Wehrle CJ, Tuma F. Physiology, liver. 2018. Murray NEA, Quam MB, Wilder-Smith A. Epidemiology of dengue: past, present and future prospects. Clinical epidemiology. 2013:299-309.

Haider Z, Ahmad FZ, Mahmood A, Waseem T, Shafiq I, Raza T, et al. Dengue fever in Pakistan: a paradigm shift; changing epidemiology and clinical patterns. Perspectives in Public Health. 2015;135(6):294-8.

Ahmad S, Aziz MA, Aftab A, Ullah Z, Ahmad MI, Mustan A. Epidemiology of dengue in Pakistan, present prevalence and guidelines for future control. Int J Mosq Res. 2017;4(6):25-32.

Kittitrakul C, Silachamroon U, Phumratanaprapin W, Krudsood S, Wilairatana P, Treeprasertsuk S. Liver function tests abnormality and clinical severity of dengue infection in adult patients. J Med Assoc Thai. 2015;98(Suppl 1):1-8.

Itha S, Kashyap R, Krishnani N, Saraswat VA, Choudhuri G, Aggarwal R. Profile of liver involvement in dengue virus infection. National

Medical Journal of India. 2005;18(3):127-129.

Shah N, Shah MM, Kumar D, Khattak IQ, Khan I. Hepatocellular Damage in the Patients presenting with Dengue Fever. Journal of Saidu Medical College, Swat. 2023;13(1):8-12.

Md Sani SS, Han WH, Bujang MA, Ding HJ, Ng KL, Amir Shariffuddin MA. Evaluation of creatine kinase and liver enzymes in identification

of severe dengue. BMC infectious diseases. 2017;17:1-11.

Nguyen T, Nguyen T, Tieu N. The impact of dengue haemorrhagic fever on liver function. Research in virology. 1997;148(4):273-7.

Mukker P, Kiran S. Platelet indices evaluation in patients with dengue fever. Int J Res Med Sci. 2018;6(6):2054.

Downloads

Published

2024-06-30

Issue

Section

Original Article

How to Cite

Effect of Dengue Fever on Liver Enzymes. (2024). International Journal of Healthcare Professions, 1(2). https://doi.org/10.71395/ijhp.1.2.2024.52-56